Information Library

Results for: Business transformation - Lower portfolio & investment risks - Globalization of Research

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Partnering to Maximize Rewards in Pharmerging Markets

    White Paper — September 15, 2011
    In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending.

  • The New Health Alliance

    White Paper — January 10, 2011
    Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders.

  • Rebalancing Risk to Transform R&D

    White Paper — June 3, 2009
    A strategic approach to re-balancing the main components of biopharma company risk: portfolio, operational and resource.

Page 1 of 1 (3 results)

Subscribe to Email Based on Your Interests

Set preferences